Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
576
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

Bei Hua Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USA;b Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USAORCID Iconhttps://orcid.org/0000-0002-4325-0929View further author information
ORCID Icon,
Xiao Lina Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USA;c Research Center of Biostatistics and Computational Pharmacy, China Pharmaceutical University, Juangsu Sheng, ChinaView further author information
,
Hans C. Leea Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Xuelin Huangd Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Rebecca S. Slack Tidwelld Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Kwang Woo Ahne Department of Medicine, Medical College of Wisconsin, CIBMTR (Center for International Blood and Marrow Transplant Research), Milwaukee, WI, USA;f Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USAView further author information
,
Zhen-Huan Hue Department of Medicine, Medical College of Wisconsin, CIBMTR (Center for International Blood and Marrow Transplant Research), Milwaukee, WI, USAView further author information
,
Elias Jabboura Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Srdan Verstovseka Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-6912-8569View further author information
ORCID Icon,
Farhad Ravandia Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Guillermo Garcia-Maneroa Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Mohamed A. Kharfan-Dabajag Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USAView further author information
,
Nasheed M. Hossainh Loyola University Chicago-Stritch School of Medicine, Maywood, IL, USAORCID Iconhttps://orcid.org/0000-0002-3278-655XView further author information
ORCID Icon,
David I. Marksi Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UKView further author information
,
Rammuriti T. Kamblej Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USAView further author information
,
Yoshihiro Inamotok Divsion of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, JapanView further author information
,
Tamila Kindwall-Kellerl Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, VA, USAView further author information
,
Ayman Saadm Division of Hematology, The Ohio State University, Columbus, OH, USAView further author information
,
Mark R. Litzown Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USAORCID Iconhttps://orcid.org/0000-0002-9816-6302View further author information
ORCID Icon,
Bipin N. Savanio Divsion of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USAView further author information
,
Gregory A. Halep Department of Hematology/Oncology, Johns Hopkins All Children’s Hospital, Petersburg, FL, USAView further author information
,
Ulrike Bacherq Department of Hematology, Inselspital, Bern University Hospital, Bern, SwitzerlandView further author information
,
Aaron T. Gerdsr Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USAView further author information
,
Jane L. Liesvelds Department of Medicine, University of Rochester Medical Center, Rochester, NY, USAView further author information
,
Celalettin Ustunt Division of Hematology/Oncology/Cell Therapy, Rush University, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0001-6896-6213View further author information
ORCID Icon,
Richard F. Olssonu Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;v Centre for Clinical Research Sormland, Uppsala University, Uppsala, SwedenView further author information
,
Andrew Dalyw Tom Baker Cancer Center, Calgary, Alberta, CanadaView further author information
,
Michael R. Grunwaldb Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC, USAView further author information
,
Melhem Solhx The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, GA, USAView further author information
,
Zachariah DeFilippy Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USAView further author information
,
Mahmoud Aljurfz Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi ArabiaView further author information
,
Baldeep WirkA Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, WA, USAView further author information
,
Gorgun AkpekB Stem Cell Transplantation and Cell Therapy, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USAView further author information
,
Taiga NishihoriC Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer and Research Institute, Tampa, FL, USAView further author information
,
Jan CernyD Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, MA, USAView further author information
,
Sachiko SeoE Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, JapanView further author information
,
Jack W. HsuF Division of Hematology & Oncology, Department of Medicine, Shands HealthCare and University of Florida, Gainesville, FL, USAView further author information
,
Richard ChamplinG Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Marcos de LimaH Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USAView further author information
,
Edwin AlyeaI Center of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USAView further author information
,
Uday Popata Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Ronald Sobecksr Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USAView further author information
,
Bart L. ScottJ Fred Hutchinson Cancer Research Center, Seattle, WA, USAView further author information
,
Hagop KantarjianK Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Jorge CortesK Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;L Division of Hematology/Oncology, Department of Medicine, Georgia Cancer Center at Augusta University, Augusta, GA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8636-1071View further author information
ORCID Icon &
Wael Sabere Department of Medicine, Medical College of Wisconsin, CIBMTR (Center for International Blood and Marrow Transplant Research), Milwaukee, WI, USACorrespondence[email protected]
View further author information
 show all
Pages 2811-2820 | Received 11 May 2020, Accepted 07 Jun 2020, Published online: 14 Jul 2020

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Fadi G. Haddad, Ghayas C. Issa, Elias Jabbour & Musa Yilmaz. (2022) Ponatinib for the treatment of adult patients with resistant or intolerant Chronic-Phase Chronic Myeloid Leukemia. Expert Opinion on Pharmacotherapy 23:7, pages 751-758.
Read now
Ok-kyong Chaekal & Koen van Besien. (2020) Allogeneic transplant for CML in chronic phase after failure of imatinib. Not needed or needlessly neglected?. Leukemia & Lymphoma 61:12, pages 2783-2784.
Read now

Articles from other publishers (4)

Nicholas J. Short, Jayastu Senapati & Elias Jabbour. (2023) An Update on the Management of Advanced Phase Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports 18:6, pages 234-242.
Crossref
Jayastu Senapati, Elias Jabbour, Hagop Kantarjian & Nicholas J. Short. (2022) Pathogenesis and management of accelerated and blast phases of chronic myeloid leukemia. Leukemia 37:1, pages 5-17.
Crossref
Christian Niederwieser & Nicolaus Kröger. (2022) Transplantation in CML in the TKI era: who, when, and how?. Hematology 2022:1, pages 114-122.
Crossref
Michele Baccarani, Francesca Bonifazi, Simona Soverini, Fausto Castagnetti, Gabriele Gugliotta, Wael Saber, Noel Estrada-Merly, Gianantonio Rosti & Robert Peter Gale. (2022) Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia. Leukemia 36:5, pages 1227-1236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.